510(k) K253069
K253069 is an FDA 510(k) premarket notification submitted by Diazyme Laboratories, Inc. for the device "Lipoprotein (a) Molarity Assay". The FDA issued a decision of Substantially Equivalent on Jun 16, 2026. The device falls under product code DFC (Lipoprotein, Low-Density, Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 866.5600. Diazyme Laboratories, Inc. has 51 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Jun 16, 2026
- Date Received
- Sep 23, 2025
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Lipoprotein, Low-Density, Antigen, Antiserum, Control
- Device Class
- Class II
- Regulation Number
- 866.5600
- Review Panel
- IM
- Submission Type
- 510(k)
Need the full FDA record for Diazyme Laboratories, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.